Matthias Gijsen
-
- Antibiotic Use and Resistance 5
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 25
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 8
-
- Bacterial Identification and Susceptibility Testing 4
-
- Pneumonia and Respiratory Infections 10
-
- Poisoning and overdose treatments 4
-
- Antifungal resistance and susceptibility 4
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Isabel SprietErwin DreesenRuth Van DaeleJoost WautersYves DebaveyeMarc FerrantePieter AnnaertKarel Allegaert
- Journals
- SHILAP Revista de lepidopterología (1 paper)Critical Care Medicine (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- BelgiumNetherlandsSweden
In The Last Decade
Matthias Gijsen
28 papers receiving 307 citations
Peers
Comparison fields: 5 of 69
- Applied Microbiology and Biotechnology 45
- Pharmacology 218
- Molecular Medicine 59
- Clinical Biochemistry 27
- Nephrology 26
Countries citing papers authored by Matthias Gijsen
This map shows the geographic impact of Matthias Gijsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Gijsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Gijsen more than expected).
Fields of papers citing papers by Matthias Gijsen
This network shows the impact of papers produced by Matthias Gijsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Gijsen. The network helps show where Matthias Gijsen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Gijsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 9 | |
| 12 | Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function | 2022 | 18 |
| 13 | 2022 | 4 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 23 | |
| 16 | 2021 | 13 | |
| 17 | 2021 | 11 | |
| 18 | 2020 | 19 | |
| 19 | 2020 | 81 | |
| 20 | 2020 | 1 |
About Matthias Gijsen
Matthias Gijsen is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 32 papers that have together received 307 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pneumonia and Respiratory Infections (10 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (5 papers), Poisoning and overdose treatments (4 papers), Antifungal resistance and susceptibility (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (45 citations), Pharmacology (218 citations) and Molecular Medicine (59 citations). Matthias Gijsen has collaborated with scholars based in Belgium, Netherlands and Sweden. Frequent co-authors include Isabel Spriet, Erwin Dreesen, Ruth Van Daele, Joost Wauters, Yves Debaveye, Marc Ferrante, Pieter Annaert, Karel Allegaert, Dirk Vlasselaers and Philippe Meersseman. Their work appears in journals such as SHILAP Revista de lepidopterología, Critical Care Medicine and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.